Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01555346 · ClinicalTrials.gov registry record
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
A clinical trial of Down Syndrome and Fetal Aneuploidy, sponsored by Sequenom.
- Completed
- Registry status
- 3,062
- Enrollment target
- 20
- Study locations
NCT01555346 is a study of Down Syndrome and Fetal Aneuploidy that has completed, run by Sequenom. The registered enrollment target is 3,062 participants, above the 2,415-participant average among 54 other Down Syndrome trials with a reported enrollment target (27% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT01555346, a study of Down Syndrome and Fetal Aneuploidy, has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 3,062 participants
- Enrollment target
- 20
- Study locations
Study Summary
Whole blood samples will be collected from high-risk pregnant women to validate the clinical performance of the SEQureDx Trisomy 21 Test.
Conditions Studied
Study Locations (20)
California
- Obstetrix Medical Group of California - Campbell
- Long Beach Memorial Medical Center - Long Beach
- Cedars-Sinai Medical Center - Los Angeles
- San Gabriel Valley Perinatal Medical Center - Monterey Park
- Scripps Clinic Carmel Valley - San Diego
Florida
- South Florida Perinatal - Miami
- Southeast Perinatal Associates - Miramar - Miramar
- Southeast Perinatal Associates - Weston - Sunrise
New Jersey
- Jersey Shore University Medical Center - Neptune City
- Saint Peter's Hospital - New Brunswick
Alabama
- University of South Alabama - Mobile
Arizona
- Visions Clinical Research Tuscon - Tucson
Hawaii
- Hawaii Pacific Health - Honolulu
Iowa
- University of Iowa Health Care - Iowa City
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,062 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01555346
The ClinicalTrials.gov registry entry for NCT01555346 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,062 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,415-participant average among 54 other Down Syndrome trials with a reported enrollment target (27% higher). The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT01555346 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01555346 about?
NCT01555346 is a clinical study titled "Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies". Whole blood samples will be collected from high-risk pregnant women to validate the clinical performance of the SEQureDx Trisomy 21 Test.
What is the current status of trial NCT01555346?
This trial is currently completed. The enrollment target is 3,062 participants. The study started on 2012-03. Estimated completion is 2015-12.
What conditions does trial NCT01555346 study?
This clinical trial studies the following conditions: Down Syndrome, Fetal Aneuploidy.
Who is sponsoring clinical trial NCT01555346?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01555346 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Florida, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Down Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RECRUITING
-
The Human Trisome Project
RECRUITING
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.